US WorldMeds
Louisville
About US WorldMeds
US WorldMeds is a closely-held, Kentucky-based specialty pharmaceutical company. Our mission is to develop, license and commercialize unique and significant specialty pharmaceuticals that address unmet medical needs or overcome limitations of existing products. Organized on March 23, 2001 by current CEO Paul Breckinridge "Breck" Jones, US WorldMeds holds true to our founder's original vision to become a substantial global operating enterprise while remaining closely-held and able to capitalize on local and experienced talent. US WorldMeds remains committed to continue to expand into a major corporate citizen and a formidable source of innovative pharmaceutical products and high-quality jobs for generations to come - both in our Louisville headquarters and our satellite offices and manufacturing facilities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $100K – $500K
- Total funding: $15.0M
- Last round: Series Unknown (Jul 2016)
- Website: usworldmeds.com
- Phone: +1 5027147914
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/us-worldmeds-2218338 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.